Alterity Therapeutics Ltd.ASX: ATH

First Patient Enrolled in Europe in Phase II Clinical trial

Mar 8, 2023 at 3:39 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment